Click on a filter below to refine your search. Remove a filter to broaden your search.
Patients undergoing surgery in 2020 versus 2019 had a more advanced clinical and pathological tumor stage.
The findings show a 14% decreased colorectal cancer mortality over 14 years.
Primary treatment modifications were tied to lower risk for toxic effects and functional decline.
The rate of all-sites cancer incidence was 28.6% lower than expected during the height of the COVID-19 pandemic response.
After 15 or more years since quitting, the cancer risk reached 50% of that associated with continued smoking.
Low diagnostic value was seen as an independent test and supplementary measure to PSA for detection of prostate cancer.